D-1204-2018 Class II Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- September 26, 2018
- Initiation Date
- September 11, 2018
- Termination Date
- September 4, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 15,384 30-count bottles
Product Description
Lamotrigine Extended-Release Tablets, USP, 200 mg, 30 tablets per bottle, Rx Only, Manufactured in INDIA, For: TORRENT PHARMA INC., 150 Allen Road, Suite 102, Basking Ridge, NJ 07920. NDC: 13668-342-30
Reason for Recall
Failed Dissolution Specifications: Out of Specification for Dissolution test (Buffer Stage) at the 5-hour time point during stability testing.
Distribution Pattern
Nationwide USA
Code Information
Lot: BFR5D002 EXP 11-2019